2005
DOI: 10.1111/j.1365-2885.2005.00647.x
|View full text |Cite
|
Sign up to set email alerts
|

Veterinary pharmacovigilance. Part 3. Adverse effects of veterinary medicinal products in animals and on the environment

Abstract: Like humans, animals may experience adverse effects when treated with medicinal products. These effects may be related to the pharmacological or toxicological properties of the substances used or they may arise because of hypersensitivity. Veterinary medicinal products may also possess the ability to harm the environment. This paper reviews the potential of veterinary medicinal products to cause adverse effects in animals and on the environment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
13
0
4

Year Published

2007
2007
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(17 citation statements)
references
References 235 publications
(348 reference statements)
0
13
0
4
Order By: Relevance
“…They promote the decomposition of dung [28] in close interaction with microorganisms and other fauna like nematodes and oligochaetes, playing a vital role in maintaining pasture hygiene, nutrient cycling, soil aeration, water percolation, humus content and pasture productivity. The issue of antiparasitics (and/or their metabolites) and their environmental effects are a controversial area [7,17,21,24,30], and the responsible authorities in the European Union (as well as in North America and Japan) require data on the effects of new veterinary antiparasiticals on dung organisms as part of the environmental risk assessment (see Phase II, Part A of the VICH Guidance Paper) [4,29]. Usually these data are obtained from laboratory tests (depending on their results semi-field studies are required), but up to now no standardized test guidelines are available.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…They promote the decomposition of dung [28] in close interaction with microorganisms and other fauna like nematodes and oligochaetes, playing a vital role in maintaining pasture hygiene, nutrient cycling, soil aeration, water percolation, humus content and pasture productivity. The issue of antiparasitics (and/or their metabolites) and their environmental effects are a controversial area [7,17,21,24,30], and the responsible authorities in the European Union (as well as in North America and Japan) require data on the effects of new veterinary antiparasiticals on dung organisms as part of the environmental risk assessment (see Phase II, Part A of the VICH Guidance Paper) [4,29]. Usually these data are obtained from laboratory tests (depending on their results semi-field studies are required), but up to now no standardized test guidelines are available.…”
Section: Introductionmentioning
confidence: 99%
“…Anthelmintics are of considerable value in agriculture, but possibly at an unevaluated cost to the greater environment [10,30]. The determination of effect values of pharmaceuticals on non target organisms are of great interest for the industry, which needs rapid, non expensive and standardized tests.…”
Section: Introductionmentioning
confidence: 99%
“…The causes and prevalence of liver diseases in dogs and cats are mostly unknown [7], but have also been related to drugs [8,9]. The role of BSEP in canine and feline liver diseases has not been studied in detail, but the same mechanism of inhibition by drugs as in humans could play a role in veterinary medicine.…”
Section: Introductionmentioning
confidence: 99%
“…Por ende, la evaluación de riesgos de estos productos farmacéuticos es un área de investigación emergente en el ámbito global (HallingSørensen et al, 1998;Daughton & Ternes, 1999;Chapman, 2006;Jjemba, 2006). Una cantidad desconocida de estos componentes son evacuados al ambiente vía las aguas residuales o cuando las heces son usadas con residuos farmacéuticos para la fertilización de tierras agrícolas (Lützhoft et al, 1999;Backhaus et al, 2000;Kümmerer, 2003;Lalumera et al, 2004;Woodward, 2006). Diferentes estudios han demostrados que muchos fármacos y sus metabolitos están presentes en ambientes acuáticos en varias partes del mundo (Bila & Dezotti, 2003).…”
unclassified